Parapharmacy
-
a commercial opportunity for all?
By
Brian Moore, Global
Retail Consultant and CEO
of
EMR-NAMNEWS
As part
of an inevitable global trend accelerated by recession,
pharmacy deregulation and the resulting increase in
self-medication, parapharmacy represents significant
opportunities for all parties involved in the provision
of consumer healthcare, everywhere. Moreover, because
of its unique potential in the midst of traditional
categories threatened by the current cut-backs in
resources, parapharmacy could have significant knock-on
effects in other retail areas.
The
entry of Multiple Grocery retail into parapharmacy, with
their leading-edge skills in retailing, a focus upon
enriching the shopping experience via a meeting of
consumer-need, combined with the provision of
equal-function private label and removal of price
controls, means that the continual loss of
Over-The-Counter (OTC) medicine business by traditional
pharmacies to Mass could accelerate, unless pharmacists
adopt equivalent commercial skills.
The Knock-On Effect On Other Categories
Whilst
special-interest groups may succeed in delaying the
change in some countries, the recession will inevitably
cause Governments to continue to seek ways of managing
the escalating costs of providing medical care to ageing
populations. They will gradually deregulate appropriate
prescription-only medicines, making them available
without prescription and where possible, allow their
sale via a wider range of outlets, at a time when
leading-edge multiples are seeking new ways of
exploiting their efficiencies. The inevitable gains
will probably encourage Governments to then apply the
process to other ‘expensive’ categories, with similar
consequences. The resulting increase in trade
concentration will in turn put more pressure on allied
categories like derma-cosmetics and nutritionals, in the
process.
The
emergence of generic medicines has in fact accelerated
the process, making parapharmacy one of the most
exciting ideas in retail, at a time when the growing
recession has taken the innovative edge off many
traditional categories. In practice this means that in
a zero-sum game, parapharmacy could steal space from
less exciting categories.
The Parapharmacy Opportunity
Essentially, parapharmacy represents the transition from
traditional pharmacy to the provision of OTC
(non-prescription) medicines, nutritional supplements,
derma-cosmetics and appropriate services in outlets that
include specialist pharmacy, drugstore, grocery,
departmental store, and luxury perfumeries/cosmetics
outlets, both independent and Mass, and via the
Internet. Parapharmacy thus has the potential to impact
traditional channels, at the expense of traditional
categories…
Consumer
need is obviously a key driver, with the consumer free
to choose between doctor, pharmacist and retail outlet,
as appropriate. The global recession is obviously
making consumers more demanding, especially in the
provision of and payment for healthcare. A consumer
becoming more conscious of value for money in healthcare
may then want to apply the ‘learnings’ in other
categories.
Efficient response to consumer need in parapharmacy
means ensuring that a service
matched with consumer expectations is provided wherever
the consumer chooses to enter the process, in a manner
that provides sufficient incentive for a repeat visit,
again adding to the demand for improved service levels
in other categories. It follows that such
service-provision be sufficiently rewarding to encourage
the service-provider to continually enhance the service
across other categories, and thus ensure
customer-retention.
Mass Role In Parapharmacy
However,
the inevitable entry of Mass retail into
high-performance parapharmacy will bring a new urgency
to the process for other players. It is obvious that
Wal-Mart, Carrefour, Tesco and Alliance Boots are
setting standards in state-of-art global retail,
especially in driving supply-chain efficiencies, retail
space optimisation, and shopper lifetime management.
Moreover, they have developed the potential of
leading-edge private label to optimise profit and outlet
differentiation.
Given
their total commitment to the enhancement of the
shopping experience, this combination of retail
strengths and scale will probably result in these four
players obtaining a significant share of the evolving
parapharmacy market, worldwide.
The
resulting increased allocation of space to healthcare
provision, nutritional supplements and derma-cosmetics
will inevitably put pressure on other categories
in-store. In other words, FMCG suppliers and retailers
will be affected by Mass involvement in parapharmacy,
making this a need-to-know topic in formulating trade
strategies in many categories.
Given
its potential impact on all aspects of
recession-retailing, parapharmacy is too important to be
left to the pharmacists…
For additional insight, see our
parapharmacy video
Date article published: March 2009
For KamTips on
'Optimising
the Parapharmacy Opportunity'
see
Namnews
–
March 2009
